Sign In

Jeff Patrick

Senior Director at Drug Development Institute

Jeff Patrick, Pharm.D., is a seasoned pharmaceutical executive with a diverse background in drug development across various therapeutic areas.

He currently leads the Drug Development Institute (DDI) at The Ohio State University Comprehensive Cancer Center, focusing on translating innovative oncology research into potential cancer treatments.

His expertise spans from preclinical and clinical research to global medical affairs, scientific strategy, drug safety, and business development.

With a Doctorate in Pharmacy from the University of Tennessee-Health Science Center, Jeff has held key roles in prominent organizations such as Nutriband Inc., Mallinckrodt, and Gilead Sciences.

His leadership has contributed to the commercialization of over 15 pharmaceutical agents, including first-in-class treatments for rare diseases.

Jeff Patrick has a profound impact on early-stage drug development, maintaining a pipeline of oncology assets in various stages of development at the DDI.

Known for leveraging collaborative resources and fostering partnerships, he creates high-value opportunities for pharmaceutical and biotech collaborators.

Jeff's vision and experience enable him to build and lead teams in different settings, from startup biotechs to multinational pharmaceutical companies, driving growth and innovation in the field.

Jeff Patrick
Add to my network

Location

Knoxville Metropolitan Area